GRAPHICAL USER INTERFACES FOR DETERMINING PERSONALIZED ENDOCANNABINOID GENOTYPES AND ASSOCIATED RECOMMENDATIONS
Patent №
US 11,612,582
Granted
2023-03-28
Filed 2020
Owner
ENDOCANNA HEALTH, INC.
Lab
—
AI components
1
kr
Assignment
Recorded
Dataset
AIPD
2023_r1 edition
Application
16760155
An example embodiment may involve (i) receiving, by a server device, deoxyribonucleic acid (DNA) information associated with a user; (ii) parsing, by the server device, the DNA information to identify one or more single nucleotide polymorphisms (SNPs)—(iii) determining, by the server device and based, on the identified SNPs, an endocannabinoid genotype of the user; (iv) determining, based on the endocannabinoid genotype of the user, a recommendation of one or more cannabinoid formulations; (v) transmitting, to a client device associated with the user, a web-based representation of a first graphical user interface; and (vi) receiving, from the client device, an indication to display a detailed representation of a particular cannabinoid formulation of the one or more cannabinoid formulations.
AI classification
Ownership
ENDOCANNA HEALTH, INC.
assignment · 545510810
Assignors
MAY, LEN, KAUFMAN, ERIC
On an employer assignment, the assignors are typically the inventors.